Volume 80, Issue 8 (November 2022)
Tehran Univ Med J 2022, 80(8): 618-624 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Parham M, Oulad Dameshghi D, Saghafi H, Sarbandy Farahani A, Karimi Matloub S, Karimi Matloub R. The effect of oral calcium on serum level of
vitamin B12 in patients with type 2 diabetes. Tehran Univ Med J 2022; 80 (8) :618-624
URL: http://tumj.tums.ac.ir/article-1-12001-en.html
URL: http://tumj.tums.ac.ir/article-1-12001-en.html
Mahmoud Parham * 
1, Davoud Oulad Dameshghi2 , Hossein Saghafi3 , Azam Sarbandy Farahani4 , Saeed Karimi Matloub4 , Rasool Karimi Matloub5
1, Davoud Oulad Dameshghi2 , Hossein Saghafi3 , Azam Sarbandy Farahani4 , Saeed Karimi Matloub4 , Rasool Karimi Matloub5
1- Department of Endocrinology, Faculty of Medicine, Qom University of Medical Sciences, Qom, Iran.
2- Department of Blood and Oncology, Faculty of Medicine, Qom University of Medical Sciences, Qom, Iran.
3- Department of Nephrology, Faculty of Medicine, Qom University of Medical Sciences, Qom, Iran.
4- Medical Student, Faculty of Medicine, Qom University of Medical Sciences, Qom, Iran.
5- Medical Student, Faculty of Medicine, Arak University of Medical Sciences, Arak, Iran
2- Department of Blood and Oncology, Faculty of Medicine, Qom University of Medical Sciences, Qom, Iran.
3- Department of Nephrology, Faculty of Medicine, Qom University of Medical Sciences, Qom, Iran.
4- Medical Student, Faculty of Medicine, Qom University of Medical Sciences, Qom, Iran.
5- Medical Student, Faculty of Medicine, Arak University of Medical Sciences, Arak, Iran
Abstract: (1211 Views)
Background: Vitamin B12 deficiency is one of the most well-known disorders due to long-term use of metformin due to interference with its absorption.
Methods: This double-blind randomized trial was conducted from June to October 2016 at Shahid Beheshti Hospital in Qom on 60 patients in the age group of 30 to 60 years with a history of type 2 diabetes for one to two years and taking metformin in the amount of one to two grams. Patients were divided into two groups of 30 people. The intervention group received metformin with 1 gram of calcium carbonate daily, and the control group received metformin without calcium. Each of the patients in the intervention group was given 200 calcium carbonate tablets. Vitamin B12 levels of the patients in both groups were measured before the start of the intervention, and they were evaluated in terms of neuropathy according to the Michigan questionnaire. Vitamin B12 of patients and neuropathy in two groups were measured before the intervention and after three months.
Results: There was a difference between the two groups in terms of gender, and no significant difference was observed between the mean ages in the two groups. The mean level of vitamin B12 before receiving calcium in group A (intervention) was lower than group B (control) (P=0.036) and after receiving calcium, the level of vitamin B12 in the intervention group increased (P=0.002). In the control group, the level of vitamin B12 decreased (P=0.030). (P=0.006), and in the control group there was no significant difference in the examination of neuropathy (P=0.2).
Methods: This double-blind randomized trial was conducted from June to October 2016 at Shahid Beheshti Hospital in Qom on 60 patients in the age group of 30 to 60 years with a history of type 2 diabetes for one to two years and taking metformin in the amount of one to two grams. Patients were divided into two groups of 30 people. The intervention group received metformin with 1 gram of calcium carbonate daily, and the control group received metformin without calcium. Each of the patients in the intervention group was given 200 calcium carbonate tablets. Vitamin B12 levels of the patients in both groups were measured before the start of the intervention, and they were evaluated in terms of neuropathy according to the Michigan questionnaire. Vitamin B12 of patients and neuropathy in two groups were measured before the intervention and after three months.
Results: There was a difference between the two groups in terms of gender, and no significant difference was observed between the mean ages in the two groups. The mean level of vitamin B12 before receiving calcium in group A (intervention) was lower than group B (control) (P=0.036) and after receiving calcium, the level of vitamin B12 in the intervention group increased (P=0.002). In the control group, the level of vitamin B12 decreased (P=0.030). (P=0.006), and in the control group there was no significant difference in the examination of neuropathy (P=0.2).
|
Conclusion: Oral calcium daily intake increases vitamin B12 levels in patients with type 2 diabetes and calcium may be able to moderate the decrease in serum vitamin B12 levels induced by metformin in patients with type 2 diabetes.
|
Type of Study: Original Article |
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
